Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

AusPAR: Nepafenac

Australian Public Assessment Report

AusPAR

AusPAR: Nepafenac [PDF, 806.53 KB]

AusPAR: Nepafenac [DOCX, 740.31 KB]

Attachment: Product Information: Nepafenac [PDF, 164 KB]

Attachment: Product Information: Nepafenac [DOC, 130.5 KB]

Attachment: Extract from Clinical Evaluation Report Nepafenac [PDF, 1.82 MB]

Attachment: Extract from Clinical Evaluation Report Nepafenac [DOCX, 2.14 MB]

Device/Product Name

Ilevro

Active ingredients

Nepafenac

AusPAR Date

23 December 2015

Published

24 December 2015

Submission Number

PM-2014-03164-1-1

Submission Type

New chemical entity

Decision

Approved

Product types

Prescription medicines